Friday, November 9th and 10th 10am-4pm Technology Licensing Course (MCLE Credit and Certificate of completion provided)UNIVERSITY OF CALIFORNIA SAN DIEGO EXTENSION Registration link:https://extension.ucsd.edu/courses-and-programs/mcle-technology-licensing-workshop?vAction=singleCourse&vCourse=LAW-80004 Contact: Julia Dunlap, email@example.com
Friday, October 19, 2018 8:00 am – 2:00 pm Microbiome and Bioinformatics Symposium UNIVERSITY OF CALIFORNIA SAN DIEGO EXTENSION Registration link: https://extension.ucsd.edu/courses-and-programs/microbiome-and-bioinformatics Contact: Felicia Murray, firstname.lastname@example.org Agenda: 8:00 am: Breakfast (Sponsored by Illumina) 8:30 am Microbiome and Human Health - An overview: Amitabh Gaur, Adjunct Professor, George Washington Medical School 9:00 am Global phylogeography and ancient evolution of the widespread
BioCentury and BayHelix Present: The China Healthcare Summit 2018 The Bridge to Innovation November 13-14, 2018 Shanghai, China Early-Bird Registration Now Open Reserve Your Seat and Save SABPA Members: Save an Additional 20% on Registration with Discount Code: SABPA2018 BioCentury and BayHelix Present: The 5th China Healthcare Summit in Shanghai November 13-14, 2018. The China
DATE: Thursday, September 6, 2018 TIME: 6:00 – 6:30 PM Registration, Networking and Light dinner 6:30 – 7:15 PM Dr. Jinglan Zhou, “Discovery of Ivacaftor, a CFTR for the Treatment of Cystic Fibrosis” 7:15 – 8:00 PM Professor John L. Wood, “Recent Efforts in the Synthesis of Complex Natural Products” PLACE: Lilly Biotechnology Center 10290 Campus
Background: The SABPA Board of Directors (BOD) is the governing body that oversees all activities of the SABPA organization. There are twenty-one (21) board directors serving a three-year term. In 2018, there are five (5) open seats on the BOD for candidates seeking election. Eligibility: An active SABPA member who possesses a high standard of
We are hiring…… Please send your application (or question) to email@example.com Scientist, in vitro pharmacology Ph.D. in Molecular Biology, Microbiology, Biochemistry or a related field Biological assay development, validation, quality control, and application in discovery research. Experience in development of SOPs, writing of research proposals and study reports. Scientist I/II, HTS and compound management Ph.D.
Biocom Educational Session Transformative Screening Platforms for Today’s Drug Discovery June 20th, 8-10 AM, 2018 Venue: Biocom McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA Registration: https://www.biocom.org/s/EventDetail?event=June-CRO-Event Do you wish to keep abreast of the new developments in cutting-edge screening technologies? Are you trying to rise to the challenge of working with
How can we accelerate successful drug discovery and development? The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes